Pot Stock Buy Alert: What Long-Term Cannabis Investors Need to Know

Even in its short history, Cannabis investing has been full of victory and defeat. In 2018, every pot stock was soaring in value. By 2019, the fortunes were reversed, with the majority of pot stocks falling by at least 50%. Here’s what you need to know: this ride is far from over. In 2020, we could see another upward surge.…

Read More

Why NOW Is Your Best Chance to Buy Pot Stocks

Last year was rough for pot investors. Most cannabis stocks fell by more than 50%. More than $10 billion in value was destroyed in a matter of months. Long gone were the days of 2018, when every pot stock was soaring to new heights. While the cannabis bear market left many investors scarred for life, it should’ve been expected. Every…

Read More

This Pot Stock Has the Most Upside in 2020!

Pot stocks are primed for another rebound. After a difficult 2019, several indicators suggest a major bull market could appear in 2020. If you’ve been waiting to invest in cannabis, now may be your best chance. The market has learned a few critical lessons over the last few months. These lessons should help guide your investment dollars. Two lessons we…

Read More

Canopy Growth (TSX:WEED) Stock Craters But it’s Still Not Time to Sell

It’s been a tough earnings season for cannabis companies, with HEXO, Tilray, and now Canopy Growth (TSX:WEED)(NYSE:CGC) turning in disappointing results. However, while investors have been quick to sell off their shares in affected companies, the industry is brand new, and the best way to get rich in the long term is to hold onto that stock. Let’s take a…

Read More

Better Cannabis Buy: Cronos (TSX:CRON) vs. Tilray (NASDAQ:TLRY)

Cannabis investors continue to experience a steep decline in the value of their investments. However, several cannabis stocks are trading close to their 52-week lows and might gain in market value as we head into 2020. Here, we look at two stocks that have corrected significantly in the last year. The stocks are Cronos (TSX:CRON)(NASDAQ:CRON) and Tilray (NASDAQ:TLRY). Cronos went…

Read More

Why Cronos (TSX:CRON) Stock Fell 14% in August

Cronos Group (TSX:CRON)(NASDAQ:CRON) was one of the best-performing pot stocks in history. In 2016, shares were worth just $0.20 apiece. This March, shares surpassed the $29 mark. A $10,000 investment would have been worth nearly $1.5 million. Over the last six months, however, shares have struggled, falling as much as 50%. Last month, the declines continued, with the stock losing 14%…

Read More

TFSA Investors: Should You Own Marijuana Stocks?

Marijuana stocks have been a hot news item over the past two years. Between legalization, global expansion and massive M&A deals, there’s been a lot to keep up with. In the lead-up to legalization, weed stocks went on a massive bull run, with stocks like Tilray Inc (NASDAQ:TLRY) rising nearly 1000% in just a few months. Since then, the marijuana sector…

Read More

Tilray (NASDAQ:TLRY): The Fall of a Weed Stock

Remember Tilray (NASDAQ:TLRY)? During last summer’s weed bubble, it was one of the most talked about marijuana producers. Rising 755% from its IPO price in just two months, TLRY gained more than any other weed stock in the same period. At the time, investors were positively euphoric about the company’s elite VC backing and access to U.S. distribution networks, both of…

Read More

Why Investors Need to Bet on This 1 Cannabis Stock

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock is on the verge of a breakout. It has burnt significant investor wealth in the last 10 months. Aurora investors have lost over 37% since October 2018. Several cannabis stocks were overvalued at the end of last year, just before Canada regularized marijuana for recreational purposes. After that euphoria died down, cannabis stocks fell significantly. Shares…

Read More

Investors: How to Prepare for the “Next Generation” of Weed Stock IPOs

The quick returns generated by weed stock IPOs are almost unprecedented in stock market history. As a case in point, consider Tilray. After its IPO, Tilray rallied 750% in the span of a few short months. Although it cooled off shortly afterward, the stock’s rise shows how quickly weed stocks can make investors wealthy. Unfortunately, with growing losses and increasing regulatory…

Read More